Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections

© 2018 American Society for Microbiology. Dried blood spot (DBS) antibiotic assays can facilitate pharmacokinetic (PK) studies in situations where venous blood sampling is logistically and/or ethically challenging. In this study, we aimed to demonstrate the validity of a DBS ceftriaxone assay in a P...

Full description

Bibliographic Details
Main Authors: Mukap, M., Sprod, C., Tefuarani, N., Laman, M., Page-Sharp, Madhu, Salman, S., Moore, Brioni, Batty, Kevin, Davis, T., Manning, L.
Format: Journal Article
Published: American Society for Microbiology 2018
Online Access:http://hdl.handle.net/20.500.11937/72156
_version_ 1848762674746228736
author Mukap, M.
Sprod, C.
Tefuarani, N.
Laman, M.
Page-Sharp, Madhu
Salman, S.
Moore, Brioni
Batty, Kevin
Davis, T.
Manning, L.
author_facet Mukap, M.
Sprod, C.
Tefuarani, N.
Laman, M.
Page-Sharp, Madhu
Salman, S.
Moore, Brioni
Batty, Kevin
Davis, T.
Manning, L.
author_sort Mukap, M.
building Curtin Institutional Repository
collection Online Access
description © 2018 American Society for Microbiology. Dried blood spot (DBS) antibiotic assays can facilitate pharmacokinetic (PK) studies in situations where venous blood sampling is logistically and/or ethically challenging. In this study, we aimed to demonstrate the validity of a DBS ceftriaxone assay in a PK study of children with severe illness from Papua New Guinea (PNG), a setting in which health care resources are limited and anemia is common. Using a previously validated liquid chromatographytandem mass spectrometry (LC-MS/MS) assay, serial plasma and DBS ceftriaxone concentrations were measured in PNG children aged 5 to 10 years with acute bacterial meningitis or severe pneumonia. The concentration-time data were incorporated into population PK models. Ten children were recruited with an admission hematocrit of 0.22 to 0.52. Raw data demonstrated good correlation between plasma and DBS concentrations (Spearman's rank correlation coefficient [rs] =0.94 [95% confidence interval, 0.91 to 0.97], P < 0.0001). A marked systematic hematocrit bias was observed, with lower hematocrits resulting in underestimation of DBS-predicted plasma concentration. After adjustment for red cell partitioning and hematocrit bias, a population PK model comparing plasma and DBS-predicted plasma concentrations did not differ in terms of key PK parameters, including clearance, volume of distribution, and residual variability. The performance of the ceftriaxone DBS assay is robust and provides reassurance that this platform can be used as a surrogate for plasma concentrations to provide valid PK and PK/pharmacodynamic studies of severely unwell children hospitalized in a resource-limited setting. It highlights the importance of hematocrit bias in validation studies of DBS assays.
first_indexed 2025-11-14T10:51:19Z
format Journal Article
id curtin-20.500.11937-72156
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:51:19Z
publishDate 2018
publisher American Society for Microbiology
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-721562018-12-13T09:34:21Z Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections Mukap, M. Sprod, C. Tefuarani, N. Laman, M. Page-Sharp, Madhu Salman, S. Moore, Brioni Batty, Kevin Davis, T. Manning, L. © 2018 American Society for Microbiology. Dried blood spot (DBS) antibiotic assays can facilitate pharmacokinetic (PK) studies in situations where venous blood sampling is logistically and/or ethically challenging. In this study, we aimed to demonstrate the validity of a DBS ceftriaxone assay in a PK study of children with severe illness from Papua New Guinea (PNG), a setting in which health care resources are limited and anemia is common. Using a previously validated liquid chromatographytandem mass spectrometry (LC-MS/MS) assay, serial plasma and DBS ceftriaxone concentrations were measured in PNG children aged 5 to 10 years with acute bacterial meningitis or severe pneumonia. The concentration-time data were incorporated into population PK models. Ten children were recruited with an admission hematocrit of 0.22 to 0.52. Raw data demonstrated good correlation between plasma and DBS concentrations (Spearman's rank correlation coefficient [rs] =0.94 [95% confidence interval, 0.91 to 0.97], P < 0.0001). A marked systematic hematocrit bias was observed, with lower hematocrits resulting in underestimation of DBS-predicted plasma concentration. After adjustment for red cell partitioning and hematocrit bias, a population PK model comparing plasma and DBS-predicted plasma concentrations did not differ in terms of key PK parameters, including clearance, volume of distribution, and residual variability. The performance of the ceftriaxone DBS assay is robust and provides reassurance that this platform can be used as a surrogate for plasma concentrations to provide valid PK and PK/pharmacodynamic studies of severely unwell children hospitalized in a resource-limited setting. It highlights the importance of hematocrit bias in validation studies of DBS assays. 2018 Journal Article http://hdl.handle.net/20.500.11937/72156 10.1128/AAC.00940-18 American Society for Microbiology restricted
spellingShingle Mukap, M.
Sprod, C.
Tefuarani, N.
Laman, M.
Page-Sharp, Madhu
Salman, S.
Moore, Brioni
Batty, Kevin
Davis, T.
Manning, L.
Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
title Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
title_full Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
title_fullStr Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
title_full_unstemmed Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
title_short Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
title_sort validation of a dried blood spot ceftriaxone assay in papua new guinean children with severe bacterial infections
url http://hdl.handle.net/20.500.11937/72156